Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

3 FTSE 100 stocks I’d never sell

| Alan Oscroft

There are some FTSE 100 (INDEXFTSE:UKX) shares that really do deserve to be held forever.

Read more »

Investing Articles

Is this the FTSE 100’s top growth stock?

| G A Chester

This FTSE 100 (INDEXFTSE: UKX) unsung hero good could be a top growth pick, says G A Chester.

Read more »

Investing Articles

3 great income stocks I’d buy today

| Harvey Jones

If you are looking for a base rate busting income these three FTSE 100 companies are a great place to…

Read more »

Investing Articles

A FTSE 100 giant with 20% upside to consider

| Rupert Hargreaves

This blue chip could have a possible upside of 20%.

Read more »

Investing Articles

Are shares in GlaxoSmithKline plc now in bargain territory?

| Paul Summers

Paul Summers casts his eyes over today's results from pharmaceutical giant GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Should you buy or sell AstraZeneca plc after FY sales fall 5%?

| Roland Head

Roland Head reviews 2016 results from AstraZeneca plc (LON:AZN) and asks whether the firm's ambitious goals deserve a buy rating.

Read more »

Investing Articles

After revenue jumps 60%, is Oxford Biodynamics plc a buy?

| Rupert Hargreaves

Could Oxford Biodynamics PLC (LON: OBD) be London's next super growth stock?

Read more »

Investing Articles

2 hot FTSE 100 dividend stocks I’d buy in February

| Peter Stephens

These two shares offer excellent income potential.

Read more »

Investing Articles

Is Neil Woodford a fool to continue pumping money into Capita plc and AstraZeneca plc?

| G A Chester

Are Capita plc (LON:CPI) and AstraZeneca plc (LON:AZN) poor investments today?

Read more »

Investing Articles

3 top picks for a 2017 starter portfolio

| Alan Oscroft

Here are three shares that could make a great start to your investing career.

Read more »

Investing Articles

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

| Peter Stephens

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is Neil Woodford’s favourite stock set to outperform in 2017?

| Rupert Hargreaves

Neil Woodford loves this company, but should you be buying?

Read more »